Cleveland-Cliffs Inc. (NYSE: CLF): J.P. Morgan started coverage with a Neutral rating and an $18 price target. That compares with a $20.77 consensus target and Tuesday’s closing print of $14.77.
Five9 Inc. (NASDAQ: FIVN): Roth MKM resumed coverage with a Buy rating and an $80 target price. The consensus target is $83.75. The shares closed over 6% lower on Tuesday at $60.05.
Infosys Ltd. (NASDAQ: INFY): J.P. Morgan started coverage with a Neutral rating and a target price of $14. The consensus target is $18.34, and shares closed on Tuesday at $15.53.
Integra Lifesciences Holdings Corp. (NASDAQ: IART): Citigroup cut its Neutral rating to Sell and its $59 target price to $39. The consensus is $57.40 for now. Tuesday’s $40.48 close was down 20% on the day after the downgrade.
I3 Verticals Inc. (NASDAQ: IIIV): BTIG Research resumed coverage with a Buy rating and a $28 price target. The posted consensus target is $31.17. The shares closed on Tuesday at $23.75.
Knight-Swift Transportation Holdings Inc. (NYSE: KNX): Stifel resumed coverage with a Buy rating and a $63 target price. The consensus target is $65.11. The stock closed on Tuesday at $55.25.
Microsoft Corp. (NASDAQ: MSFT): Jefferies reiterated a Buy rating. Its $350 target price is higher than the $331.45 consensus target and Tuesday’s close at $315.26.
Myriad Genetics Inc. (NASDAQ: MYGN): When Goldman Sachs upgraded the stock Buy from Sell, it also raised its $18 target price to $25, above the $21.56 consensus figure. Tuesday’s close at $22.68 was up over 12% for the day on the upgrade.
Nucor Corp. (NYSE: NUE) J.P. Morgan started coverage with an Underweight rating and a $130 target price. The consensus target is $148.46. Shares were last seen on Tuesday trading at $136.92.
Quanterix Inc. (NASDAQ: QTRX): The Goldman Sachs upgrade to Buy from Neutral included a target price hike to $27 from $13. The consensus target is $19.25. The stock closed on Tuesday at $21.18, which was up 13% for the day on the upgrade.
ResMed Inc. (NYSE: RMD): UBS initiated coverage with a Buy rating and a $290 target price. The consensus target is $258. Tuesday’s final trade was for $222.55 a share.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
